Cases 51 - 60 of 275
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01042
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2021cv01019
Counter Defendant:
Vertex Pharmaceuticals Incorporated
Counter Claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. LUPIN LTD. et al
as 3:2021cv13247
Counter Defendant:
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and AUSPEX PHARMACEUTICALS, INC.
Counter Claimant:
LUPIN PHARMACEUTICALS, INC. and LUPIN LTD.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited et al
as 1:2021cv00900
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 1:2021cv11258
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al
as 1:2021cv00530
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant:
Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff:
Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Lupin Limited et al
as 1:2021cv00314
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2021cv00229
Defendant:
Lupin Pharmaceuticals, Inc., Lupin Limited, Lupin Atlantis Holdings, S.A. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 1:2020cv19379
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
